Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Operating Income Growth (1y) (2010 - 2026)

Charles River Laboratories International (CRL) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 13.79%
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 48.29%
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 31.33%
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 33.00%
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 0.00%
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 14.08%
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 14.49%
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 17.41%
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 14.47%
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn 19.73%

Historic Data

Download Data
DateValue
Jun 27, 2026 19.73%
Dec 27, 2025 -69.03%
Sep 27, 2025 13.96%
Jun 28, 2025 -33.97%
Mar 29, 2025 -40.73%
Dec 28, 2024 -226.15%
Sep 28, 2024 -22.51%
Jun 29, 2024 -8.06%
Mar 30, 2024 -24.97%
Dec 30, 2023 -18.86%
Sep 30, 2023 0.35%
Jul 1, 2023 -11.99%
Apr 1, 2023 12.85%
Dec 31, 2022 -5.21%
Sep 24, 2022 -3.10%
Jun 25, 2022 36.25%
Mar 26, 2022 20.27%
Dec 25, 2021 34.03%
Sep 25, 2021 17.36%
Jun 26, 2021 79.18%